Literature DB >> 25146364

The impact of heart failure and left ventricular dysfunction in predicting stroke, thromboembolism, and mortality in atrial fibrillation patients: a systematic review.

Megha Agarwal1, Stavros Apostolakis1, Deirdre A Lane1, Gregory Y H Lip2.   

Abstract

PURPOSE: Atrial fibrillation (AF) is commonly associated with structural heart disease. Although heart failure (HF) has been proposed as a risk factor for stroke, the coexistence of the 2 diseases increases disproportionally the risk of thromboembolic events. Our objective was to conduct a systematic review to assess the effect of HF on the end points of stroke, systemic embolism (SE), or mortality in patients with AF.
METHODS: A literature search was performed to identify studies that examined stroke/ SE in relation to AF and HF. Overall, 405 articles satisfied the preinclusion criteria.
FINDINGS: In studies in which HF was based on a clinical diagnosis, HF independently increased stroke/SE in 5 of 13 studies, conferring 1.6- to 3.1-fold increase in risk. When HF was defined as impaired left ventricular (LV) function on echocardiography, the additive risk was evident in 4 of 6 studies, with 1.7- to 2.6-fold increase in the risk of stroke/SE. The data about HF with preserved ejection fraction were less robust, although a recent presentation with acute decompensated HF increased the risk of stroke/SE, irrespective of ejection fraction. IMPLICATIONS: LV systolic impairment as identified by echocardiography is an independent risk factor for stroke/SE, although the magnitude by which it increases the risk of stroke cannot be precisely quantified. Whether a clinical diagnosis of HF is a significant risk factor remains inconclusive, although when the diagnosis is certain (recent decompensation requiring hospitalization), it does seem to be a significant risk factor irrespective of LV systolic function.
Copyright © 2014 Elsevier HS Journals, Inc. All rights reserved.

Entities:  

Keywords:  atrial fibrillation; cardiac failure; risk factors; stroke; thromboembolism

Mesh:

Year:  2014        PMID: 25146364     DOI: 10.1016/j.clinthera.2014.07.015

Source DB:  PubMed          Journal:  Clin Ther        ISSN: 0149-2918            Impact factor:   3.393


  14 in total

Review 1.  European Heart Rhythm Association (EHRA)/European Association of Cardiovascular Prevention and Rehabilitation (EACPR) position paper on how to prevent atrial fibrillation endorsed by the Heart Rhythm Society (HRS) and Asia Pacific Heart Rhythm Society (APHRS).

Authors:  Bulent Gorenek; Antonio Pelliccia; Emelia J Benjamin; Giuseppe Boriani; Harry J Crijns; Richard I Fogel; Isabelle C Van Gelder; Martin Halle; Gulmira Kudaiberdieva; Deirdre A Lane; Torben Bjerregaard Larsen; Gregory Y H Lip; Maja-Lisa Løchen; Francisco Marin; Josef Niebauer; Prashanthan Sanders; Lale Tokgozoglu; Marc A Vos; David R Van Wagoner; Laurent Fauchier; Irina Savelieva; Andreas Goette; Stefan Agewall; Chern-En Chiang; Márcio Figueiredo; Martin Stiles; Timm Dickfeld; Kristen Patton; Massimo Piepoli; Ugo Corra; Pedro Manuel Marques-Vidal; Pompilio Faggiano; Jean-Paul Schmid; Ana Abreu
Journal:  Eur J Prev Cardiol       Date:  2016-11-04       Impact factor: 7.804

Review 2.  European Heart Rhythm Association (EHRA)/European Association of Cardiovascular Prevention and Rehabilitation (EACPR) position paper on how to prevent atrial fibrillation endorsed by the Heart Rhythm Society (HRS) and Asia Pacific Heart Rhythm Society (APHRS).

Authors:  Bulent Gorenek; Antonio Pelliccia; Emelia J Benjamin; Giuseppe Boriani; Harry J Crijns; Richard I Fogel; Isabelle C Van Gelder; Martin Halle; Gulmira Kudaiberdieva; Deirdre A Lane; Torben Bjerregaard Larsen; Gregory Y H Lip; Maja-Lisa Løchen; Francisco Marín; Josef Niebauer; Prashanthan Sanders; Lale Tokgozoglu; Marc A Vos; David R Van Wagoner; Laurent Fauchier; Irina Savelieva; Andreas Goette; Stefan Agewall; Chern-En Chiang; Márcio Figueiredo; Martin Stiles; Timm Dickfeld; Kristen Patton; Massimo Piepoli; Ugo Corra; Pedro Manuel Marques-Vidal; Pompilio Faggiano; Jean-Paul Schmid; Ana Abreu
Journal:  Europace       Date:  2017-02-01       Impact factor: 5.214

3.  How do anticoagulated atrial fibrillation patients who suffer ischemic stroke or spontaneous intracerebral hemorrhage differ?

Authors:  Heidi Lehtola; Juha Hartikainen; Päivi Hartikainen; Tuomas Kiviniemi; Ilpo Nuotio; Antti Palomäki; Antti Ylitalo; K E Juhani Airaksinen; Pirjo Mustonen
Journal:  Clin Cardiol       Date:  2018-05-10       Impact factor: 2.882

Review 4.  Emerging Tools for Stroke Prevention in Atrial Fibrillation.

Authors:  Christos Voukalis; Gregory Y H Lip; Eduard Shantsila
Journal:  EBioMedicine       Date:  2016-01-15       Impact factor: 8.143

5.  Resolution of Left Atrial Appendage Thrombus with Apixaban in a Patient with Heart Failure.

Authors:  Takenori Okada; Yuji Takaekou; Naomi Idei; Norihiko Ohashi; Shunichi Kaseda
Journal:  Intern Med       Date:  2017-09-25       Impact factor: 1.271

Review 6.  Management of Arrhythmias in Heart Failure.

Authors:  Daniele Masarone; Giuseppe Limongelli; Marta Rubino; Fabio Valente; Rossella Vastarella; Ernesto Ammendola; Rita Gravino; Marina Verrengia; Gemma Salerno; Giuseppe Pacileo
Journal:  J Cardiovasc Dev Dis       Date:  2017-02-28

Review 7.  Heart Failure and Stroke.

Authors:  Katja Schumacher; Jelena Kornej; Eduard Shantsila; Gregory Y H Lip
Journal:  Curr Heart Fail Rep       Date:  2018-10

8.  Long-Term Outcomes of Real-World Korean Patients with Atrial-Fibrillation-Related Stroke and Severely Decreased Ejection Fraction.

Authors:  Jin Man Jung; Yong Hyun Kim; Sungwook Yu; Kyungmi O; Chi Kyung Kim; Tae Jin Song; Yong Jae Kim; Bum Joon Kim; Sung Hyuk Heo; Kwang Yeol Park; Jeong Min Kim; Jong Ho Park; Jay Chol Choi; Man Seok Park; Joon Tae Kim; Kang Ho Choi; Yang Ha Hwang; Jong Won Chung; Oh Young Bang; Gyeong Moon Kim; Woo Keun Seo
Journal:  J Clin Neurol       Date:  2019-10       Impact factor: 3.077

Review 9.  Atrial fibrillation in heart failure: what should we do?

Authors:  Dipak Kotecha; Jonathan P Piccini
Journal:  Eur Heart J       Date:  2015-09-28       Impact factor: 29.983

10.  A meta-epidemiological study of subgroup analyses in cochrane systematic reviews of atrial fibrillation.

Authors:  Miney Paquette; Ahlam Mohammed Alotaibi; Robby Nieuwlaat; Nancy Santesso; Lawrence Mbuagbaw
Journal:  Syst Rev       Date:  2019-10-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.